CompletedNot Applicable

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)

United States134 participantsStarted 2020-11-12

Plain-language summary

Insomnia is common in people who are in treatment for alcohol use disorder. It can impact both sleep quality and daytime functioning, as well as make it harder to treat the underlying alcohol use disorder. This study is looking at two types of therapy to help manage insomnia specifically for people also in treatment for alcohol use disorder.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meet probable Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Alcohol Use Disorder with ≤12 months of abstinence * Planned enrollment into an abstinence-based treatment program * Meet probable DSM-5 criteria for chronic insomnia * Access to a video chat-capable device and reliable Wi-Fi network Exclusion Criteria: * Diagnosis of, or high suspicion for, sleep disorders other than insomnia * Meet probable DSM-5 criteria for bipolar disorder, psychotic disorder, or post-traumatic stress disorder (PTSD) * Terminal or progressive physical illness (e.g., cancer), neurological degenerative disease (e.g., dementia), or presence of an unstable medical condition that is the specific cause of insomnia * Self-reported pregnancy or intention to become pregnant during the study

What they're measuring

Score from the insomnia severity index (ISI)

Timeframe: Immediately post treatment

Percent days abstinent from alcohol as documented in the timeline follow-back (TLFB)

Timeframe: Immediately post treatment

Trial details

NCT IDNCT04457674

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-31

View on ClinicalTrials.gov More Insomnia trials